TRIM28 (tripartite motif containing 28) is a multifunctional E3 ligase that serves as a central regulator of chr19 organization and immune responses. (a) Primary function: TRIM28 acts as a transcriptional corepressor and E3 SUMO ligase, functioning as a cofactor for KRAB zinc finger proteins in silencing transposable elements and establishing heterochromatin 1. It facilitates chr19 compartmentalization through phase separation mechanisms involving H3K9me2/3-marked nucleosomal arrays 2. (b) Mechanism: TRIM28 promotes SUMOylation of multiple target proteins, including NLRP3 to enhance inflammasome activation 3, SARS-CoV-2 nucleocapsid protein to increase viral virulence 4, and ACSL4 to regulate neuronal ferroptosis 5. It also functions as an E3 ubiquitin ligase, promoting K63-linked ubiquitination of RIPK1 to activate NF-κB signaling 6. (c) Disease relevance: TRIM28 suppresses antitumor immunity through the SETDB1-TRIM28 complex 7 and promotes anti-PD-1 resistance by recruiting myeloid-derived suppressor cells via CXCL1 upregulation 6. It also contributes to spinal cord injury pathology through ferroptosis regulation 5. (d) Clinical significance: TRIM28 represents a potential therapeutic target for cancer immunotherapy and neurological disorders, with FDA-approved drugs like Rutin hydrate showing promise in preclinical models 5.